
|Videos|May 23, 2022
Trastuzumab Deruxtecan Treatment for Metastatic HER2+ Breast Cancer with Brain Metastases
Experts have a conversation of the use of trastuzumab deruxtecan therapy for patients with progressive brain metastases while weighing common toxicities and clinical trial data.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
2
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
3
How Are Key Lymphoma Data From ASCO and EHA 2026 Shaping Treatment?
4
Binimetinib Tablets Receive Tentative FDA Approval in Melanoma/NSCLC
5















































































